Trial Outcomes & Findings for Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device (NCT NCT02718963)
NCT ID: NCT02718963
Last Updated: 2020-11-12
Results Overview
Maximal pressure, integral, rise time, and duration in the regions of VP and TB (the time interval over the VP and TB integral). The maximal pressure of low pharynx (LP) (C in supplementary 1), maximal pre-upper esophageal sphincter (UES) pressure (F in supplementary 1), maximal cricopharyngeus (CP) pressure (D in supplementary 1), minimal upper esophageal sphincter (UES) pressure, upper esophageal sphincter (UES) activity time (the interval between pre-upper esophageal sphincter (UES) peak and post-upper esophageal sphincter (UES) peak; G in supplementary 1), and nadir upper esophageal sphincter (UES) pressure duration in the region of upper esophageal sphincter (UES).
COMPLETED
NA
20 participants
During the electrical stimulation and electrical stimulation effects of Velopharynx, tongue base, lower pharynx and upper esophageal sphincter
2020-11-12
Participant Flow
There was no significant event in the study after participant enrollment
Participant milestones
| Measure |
Control Group
* control group(N=10): who does not have dysphagia symptom
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
Experimental Group
* experimental group(N=10): who have dysphagia symptoms
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
10
|
|
Overall Study
COMPLETED
|
9
|
9
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Control Group
n=10 Participants
* control group(N=10): who does not have dysphagia symptom
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
Experimental Group
n=10 Participants
* experimental group(N=10): who have dysphagia symptoms
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
51.6 years
STANDARD_DEVIATION 11.99 • n=10 Participants
|
65.9 years
STANDARD_DEVIATION 13.06 • n=10 Participants
|
58.75 years
STANDARD_DEVIATION 12.5 • n=20 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=10 Participants
|
2 Participants
n=10 Participants
|
6 Participants
n=20 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=10 Participants
|
8 Participants
n=10 Participants
|
14 Participants
n=20 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
South Korea
|
10 participants
n=10 Participants
|
10 participants
n=10 Participants
|
20 participants
n=20 Participants
|
|
Disease
Stroke
|
0 Participants
n=10 Participants
|
4 Participants
n=10 Participants
|
4 Participants
n=20 Participants
|
|
Disease
Brain tumor
|
0 Participants
n=10 Participants
|
1 Participants
n=10 Participants
|
1 Participants
n=20 Participants
|
|
Disease
Cerebral palsy
|
0 Participants
n=10 Participants
|
1 Participants
n=10 Participants
|
1 Participants
n=20 Participants
|
|
Disease
Guillain-Barre syndrome
|
0 Participants
n=10 Participants
|
1 Participants
n=10 Participants
|
1 Participants
n=20 Participants
|
|
Disease
Spinal cord injury
|
0 Participants
n=10 Participants
|
1 Participants
n=10 Participants
|
1 Participants
n=20 Participants
|
|
Disease
Unknown
|
0 Participants
n=10 Participants
|
2 Participants
n=10 Participants
|
2 Participants
n=20 Participants
|
|
Disease
Healthy
|
10 Participants
n=10 Participants
|
0 Participants
n=10 Participants
|
10 Participants
n=20 Participants
|
PRIMARY outcome
Timeframe: During the electrical stimulation and electrical stimulation effects of Velopharynx, tongue base, lower pharynx and upper esophageal sphincterMaximal pressure, integral, rise time, and duration in the regions of VP and TB (the time interval over the VP and TB integral). The maximal pressure of low pharynx (LP) (C in supplementary 1), maximal pre-upper esophageal sphincter (UES) pressure (F in supplementary 1), maximal cricopharyngeus (CP) pressure (D in supplementary 1), minimal upper esophageal sphincter (UES) pressure, upper esophageal sphincter (UES) activity time (the interval between pre-upper esophageal sphincter (UES) peak and post-upper esophageal sphincter (UES) peak; G in supplementary 1), and nadir upper esophageal sphincter (UES) pressure duration in the region of upper esophageal sphincter (UES).
Outcome measures
| Measure |
Control Group
n=10 Participants
* control group(N=10): who does not have dysphagia symptom
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
Experimental Group
n=10 Participants
* experimental group(N=10): who have dysphagia symptoms
* apply Synchronized Electrical Stimulation Device
* before apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
* during apply the synchronized electrical stimulation device, we will evaluate the high resolution manometry for evaluation of deglutition function
Synchronized Electrical Stimulation Device: electrical stimulation at muscles which related with deglutition
|
|---|---|---|
|
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
Control, pressure of VP, thin
|
162.04 mmHg
Standard Deviation 39.67
|
129.66 mmHg
Standard Deviation 45.58
|
|
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
NMES, pressure of VP, thin
|
200.90 mmHg
Standard Deviation 70.61
|
170.66 mmHg
Standard Deviation 77.10
|
|
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
Control, pressure of tongue base, thick
|
81.59 mmHg
Standard Deviation 44.51
|
136.40 mmHg
Standard Deviation 27.20
|
|
Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter.
NMES, pressure of tongue base, thick
|
109.22 mmHg
Standard Deviation 54.36
|
151.26 mmHg
Standard Deviation 34.86
|
Adverse Events
Control Group
Experimental Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Ju Seok Ryu
Seoul National University Bundang Hospital, Seoul National University College of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place